Elevated microRNA-126 is associated with high vascular endothelial growth factor receptor 2 expression levels and high microvessel density in colorectal cancer

Oncology Letters

Volumn 2, Issue 6, 2011, Pages 1101-1106

  Hansen, Torben Frøstrup ^a   Andersen, Claus Lindbjerg ^b   Nielsen, Boye Schnack ^c   Spindler, Karen Lise Garm ^a   Sørensen, Flemming Brandt ^a   Lindebjerg, Jan ^c   Brandslund, Ivan ^a   Jakobsen, Anders ^a  

^a LILLEBAELT HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c Exiqon AS   (Denmark)

Author keywords

Angiogenesis; Colorectal neoplasm; MicroRNAs; Microvessel density; Vascular endothelial growth factor receptor 2

Indexed keywords

CALDESMON; ENDOGLIN; MICRORNA; MICRORNA 126; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ANGIOGENESIS; ARTICLE; COLORECTAL CANCER; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MALE; PROTEIN EXPRESSION;

EID: 80052713735     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.372     Document Type: Article

References (25)

1. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6, 1990.
2. Ferrara N, Gerber HP and LeCouter J: The biology of VEGF and its receptors. Nat Med 9: 669-676, 2003.
3. Wagner AD, Arnold D, Grothey AA, Haerting J and Unverzagt S: Anti-angiogenic therapies for metastatic colorectal cancer. Cochrane Database Syst Rev 8: CD005392, 2009.
4. Hua Z, Lv Q, Ye W, et al: MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. Plos One 1: E116, 2006.
5. Kuehbacher A, Urbich C, Zeiher AM and Dimmeler S: Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 101: 59-68, 2007.
6. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY and Srivastava D: miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15: 272-284, 2008.
7. Guo C, Sah JF, Beard L, Willson JK, Markowitz SD and Guda K: The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer 47: 939-946, 2008.
8. Nicoli S, Standley C, Walker P, Hurlstone A, Fogarty KE and Lawson ND: MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature 464: 1196-1200, 2010.
9. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R and Olson EN: The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15: 261-271, 2008.
10. Esquela-Kerscher A and Slack FJ: Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
11. Filipowicz W, Bhattacharyya SN and Sonenberg N: Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114, 2008.
12. Faber C, Kirchner T and Hlubek F: The impact of microRNAs on colorectal cancer. Virchows Arch 454: 359-367, 2009.
13. Michael MZ, O'Connor SM, van Holst Pellekaan NG, Young GP and James RJ: Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1: 882-891, 2003.
14. Yamamichi N, Shimomura R, Inada K, et al: Locked nucleic acid insitu hybridization analysis of miR-21 expression during colorectal cancer development. Clin Cancer Res 15: 4009-4016, 2009.
15. Díaz R, Silva J, Garcia JM, Lorenzo Y, Garcia V, Pena C, Rodriguez R, Munoz C, Garcia F, Bonilla F and Dominguez G: Deregulated expression of miR-106a predicts survival in human colon cancer patients. Genes Chromosomes Cancer 47: 794-802, 2008.
16. Schepeler T, Reinert JT, Ostenfeld MS, et al: Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 68: 6416-6424, 2008.
17. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM and Harris CC: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. Jama 299: 425-436, 2008.
18. Hansen TF, Spindler KL, Lorentzen KA, Olsen DA, Andersen RF, Lindebjerg J, Brandslund I and Jakobsen A: Quantitative analysis of vascular endothelial growth factor receptors 1 and 2 in colorectal cancer. Mol Med Reports 2: 787-792, 2009.
19. Hansen TF, Sorensen FB, Spindler KL, Olsen DA, Andersen RF, Lindebjerg J, Brandslund I and Jakobsen A: Microvessel density and the association with single nucleotide polymorphisms of the vascular endothelial growth factor receptor 2 in patients with colorectal cancer. Virchows Arch 456: 251-260, 2010.
20. Andersen CL, Jensen JL and Orntoft TF: Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64: 5245-5250, 2004.
21. Jorgensen S, Baker A, Moller S and Nielsen BS: Robust one-day insitu hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods 52: 375-381, 2010.
22. Kuhnert F, Mancuso MR, Hampton J, Stankunas K, Asano T, Chen CZ and Kuo CJ: Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development 135: 3989-3993, 2008.
23. Ionov Y, Peinado MA, Malkhosyan S, Shibata D and Perucho M: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363: 558-561, 1993.
24. Des GG, Uzzan B, Nicolas P, Cucherat M, Morere JF, Benamouzig R, Breau JL and Perret GY: Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br J Cancer 94: 1823-1832, 2006.
25. Kuehbacher A, Urbich C and Dimmeler S: Targeting microRNA expression to regulate angiogenesis. Trends Pharmacol Sci 29: 12-15, 2008.